Search results for "CARDIOVASCULAR DISEASE"

showing 10 items of 2332 documents

Peripheral arterial disease and its clinical significance in nonagenarians

2008

The purpose of this study was to characterize the prevalence and clinical features of peripheral arterial disease (PAD) among 90-year-old individuals and to assess its relationship to lower extremity functional status and survival over one year.A prospective, population- based study of all 90-year-old residents of Jyväskylä, Finland. Fifty-eight out of the 79 registered residents were examined for ankle-brachial index (ABI). Lower extremity functional status was assessed as self-reported difficulty in performing specific physical activities of daily living (PADL). In a subgroup of 36 individuals, lower extremity functioning was further assessed by measuring walking endurance and walking vel…

Agingmedicine.medical_specialtyActivities of daily livingArterial diseasePopulation030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRisk FactorsStatistical significanceInternal medicineActivities of Daily LivingHumansMedicineClinical significancecardiovascular diseases030212 general & internal medicineeducationAgedAged 80 and overPeripheral Vascular Diseaseseducation.field_of_studybusiness.industryPeripheralSurvival Ratebody regionsPhysical therapyFunctional statusGeriatrics and Gerontologymedicine.symptombusinesshuman activitiesLocomotionAging Clinical and Experimental Research
researchProduct

What are the roles of calorie restriction and diet quality in promoting healthy longevity?

2014

Epidemiological and experimental data indicate that diet plays a central role in the pathogenesis of many age-associated chronic diseases, and in the biology of aging itself. Data from several animal studies suggest that the degree and time of calorie restriction (CR) onset, the timing of food intake as well as diet composition, play major roles in promoting health and longevity, breaking the old dogma that only calorie intake is important in extending healthy lifespan. Data from human studies indicate that long-term CR with adequate intake of nutrients results in several metabolic adaptations that reduce the risk of developing type 2 diabetes, hypertension, cardiovascular disease and cance…

Agingmedicine.medical_specialtyDisease preventionTime Factorsmedia_common.quotation_subjectLongevityCalorie restrictionNutritional StatusPhysiologyType 2 diabetesDiseaseBiologyVegetarian dietBiochemistryCalorie restriction Diet quality Health Lifespan Vegetarian diet Disease preventionLife ExpectancyNutrientNeoplasmsInternal medicinemedicineAnimalsHumansLife StyleMolecular BiologyCalorie restrictionCaloric Restrictionmedia_common2. Zero hungerLifespanAge FactorsLongevityCalorie restriction; Diet quality; Disease prevention; Health; Lifespan; Vegetarian diet; Age Factors; Aging; Animals; Cardiovascular Diseases; Energy Metabolism; Humans; Longevity; Neoplasms; Nutritional Status; Time Factors; Caloric Restriction; Diet; Life Expectancy; Life Style; Risk Reduction BehaviorVegan Dietmedicine.diseaseDiet3. Good healthEndocrinologyNeurologyHealthCardiovascular DiseasesDietary Reference IntakeAnimal studiesEnergy MetabolismRisk Reduction BehaviorDiet qualityBiotechnology
researchProduct

The prognostic role of the cardio-ankle vascular index

2018

The well‐performed meta‐analysis of Matsushita et al represents an important contribution to the knowledge about the clinical meaning of arterial stiffness parameters, suggesting that CAVI is associated positively with a slightly increased risk of CV events, but not of total mortality. However, caution is needed in interpreting these findings, due to the limited number of prospective studies eligible for the meta‐analysis and the relatively low number of subjects included, mostly living in Japan or China. Therefore, additional studies, preferably with a prospective design and involving participants also from non‐Asian countries, are required to better define the prognostic role and the clin…

Agingmedicine.medical_specialtyEndocrinology Diabetes and MetabolismHypertension and Cardiovascular OutcomesPulse Wave Analysis030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesVascular Stiffness0302 clinical medicineatherosclerosiMeta-Analysis as TopicRisk FactorsOscillometryInternal medicineInternal MedicinemedicineHypertension generalHumans030212 general & internal medicineCardio-ankle vascular indexhypertension-generalbusiness.industryPrognosisCardio Ankle Vascular IndexCardiovascular DiseasesCardiologyhypertension-vascular diseaseCardiology and Cardiovascular Medicinebusinessarterial complianceAlgorithms
researchProduct

The emerging role of miRNA-132/212 cluster in neurologic and cardiovascular diseases: Neuroprotective role in cells with prolonged longevity

2021

Abstract miRNA-132/212 are small regulators of gene expression with a function that fulfills a vital function in diverse biological processes including neuroprotection of cells with prolonged longevity in neurons and the cardiovascular system. In neurons, miRNA-132 appears to be essential for controlling differentiation, development, and neural functioning. Indeed, it also universally promotes axon evolution, nervous migration, plasticity as well, it is suggested to be neuroprotective against neurodegenerative diseases. Moreover, miRNA-132/212 disorder leads to neural developmental perturbation, and the development of degenerative disorders covering Alzheimer’s, Parkinson’s, and epilepsy’s …

Agingmedicine.medical_specialtyNeurologyDegenerative Disordermedia_common.quotation_subjectNeuroprotection03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmicroRNAAnimalsHumansMedicineMyocytes CardiacMolecular Targeted TherapyAxonCellular SenescenceComputingMilieux_MISCELLANEOUS030304 developmental biologymedia_commonNeurons0303 health sciencesbusiness.industryNeurodegenerationAutophagyLongevityNeurodegenerative Diseasesmedicine.diseaseNeuroprotection3. Good healthMicroRNAsmedicine.anatomical_structureGene Expression RegulationCardiovascular DiseasesbusinessNeuroscience030217 neurology & neurosurgeryDevelopmental Biology
researchProduct

PCSK9: A link between air pollution and cardiovascular disease?

2019

Air PollutantsEpidemiologybusiness.industryAir pollutionDiseasemedicine.disease_causeCardiovascular DiseasesEnvironmental healthAir PollutionMedicineHumansProprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessLink (knot theory)European journal of preventive cardiology
researchProduct

Up in the air: links between the environment and cardiovascular disease

2019

Air PollutantsEvidence-Based MedicinePhysiologybusiness.industryAcousticsAir pollutionEnvironmental ExposureCardiovascular Research OnlifePrognosisEditors’ Cornermedicine.disease_causeCardiovascular SystemRisk AssessmentNoiseCardiovascular DiseasesRisk FactorsPhysiology (medical)AnimalsHumansMedicineNoiseCardiology and Cardiovascular MedicinebusinessCardiovascular Research
researchProduct

Perturbation of metabolic pathways mediates the association of air pollutants with asthma and cardiovascular diseases.

2018

Background: Epidemiologic evidence indicates common risk factors, including air pollution exposure, for respiratory and cardiovascular diseases, suggesting the involvement of common altered molecular pathways. Objectives: The goal was to find intermediate metabolites or metabolic pathways that could be associated with both air pollutants and health outcomes (“meeting-in-the-middle”), thus shedding light on mechanisms and reinforcing causality. Methods: We applied a statistical approach named ‘meet-in-the-middle’ to untargeted metabolomics in two independent case-control studies nested in cohorts on adult-onset asthma (AOA) and cardio-cerebrovascular diseases (CCVD). We compared the results …

Air pollution Untargeted metabolomics Metabolic pathways Adult-onset asthma Cardio-cerebrovascular diseases0301 basic medicineChronic exposureAdultAir pollution exposureAir pollutionAir pollution010501 environmental sciencesmedicine.disease_cause01 natural sciencesSettore MED/01 - Statistica Medica03 medical and health sciencesAir pollutantsMD MultidisciplinarymedicineHumans0105 earth and related environmental sciencesGeneral Environmental ScienceAsthmaCardio-cerebrovascular diseasesAir PollutantsUntargeted metabolomicsOdds ratioEnvironmental Exposuremedicine.diseaseAsthmaMetabolic pathway030104 developmental biologyUntargeted metabolomicsMetabolic pathwaysCardiovascular DiseasesCase-Control StudiesImmunologyEXPOsOMICS ConsortiumEnvironmental SciencesMetabolic Networks and PathwaysAdult-onset asthmaEnvironment international
researchProduct

Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study.

2015

INTRODUCTION AND OBJECTIVE Blood pressure variability (BPV) within 24 h or between visits has been found to represent an independent risk factor for cardiovascular disease. The present study was aimed at determining whether a clinical significance can be given also to the BP variations occurring within a single clinical visit. METHODS BPV was quantified as coefficient of variation and as standard deviation (SD) of the mean of three systolic SBP values within a visit in the context of a large-cross subclinical survey (BP-CARE) of treated hypertensive patients living in Eastern European countries. The study population was divided into coefficient of variation and SD quartiles and for each qua…

Ambulatory BPBlood GlucoseMalemedicine.medical_specialtyPhysiologySystoleCoefficient of variationClinic blood pressureContext (language use)Blood PressureMetabolic profileBP variabilityRisk FactorsInternal medicineCardiovascular DiseaseInternal MedicinemedicinePrevalenceHumansClinical significanceRisk factorAgedbusiness.industryRisk FactorBlood Pressure DeterminationMiddle AgedCardiovascular riskEastern europeanEuropeEndocrinologyBlood pressureCholesterolQuartileCardiovascular DiseasesHypertensionPopulation studyFemaleCardiology and Cardiovascular MedicinebusinessHumanJournal of hypertension
researchProduct

Acquired and Hereditary Angioedema: Pathogenesis and Therapy

1988

There are two main pathogenetic ways by which angioedema can develop. These pathways are completely different and lead to completely different diseases, which may have angioedema of the skin in common. Most cases of cutaneous angioedema develop with involvement of the mast cell and its mediators; especially histamine is considered to play a major role. The exact pathogenesis, however, is not known. This type of angioedema is assumed to be related to urticaria for several reasons: 1 Often it appears alternately with urticaria 2 It responds to antihistaminic drugs 3 The same causes may provoke either urticaria or angioedema

Angioedemabusiness.industryfood and beveragesMast cellmedicine.diseasePathogenesischemistry.chemical_compoundmedicine.anatomical_structurechemistryimmune system diseasesImmunologyHereditary angioedemamedicineAntihistaminic drugscardiovascular diseasesmedicine.symptomskin and connective tissue diseasesbusinessHistamine
researchProduct

A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working grou…

2016

The US National Cancer Institute estimates that cardiotoxicity (CTX) from target therapy refers mostly to four groups of drugs: epidermal growth factor receptor 2 inhibitors, angiogenic inhibitors, directed Abelson murine leukemia viral oncogene homolog inhibitors, and proteasome inhibitors. The main cardiotoxic side-effects related to antiepidermal growth factor receptor 2 therapy are left ventricular systolic dysfunction and heart failure. Angiogenesis inhibitors are associated with hypertension, left ventricular dysfunction/heart failure, myocardial ischemia, QT prolongation, and thrombosis. Moreover, other agents may be related to CTX induced by treatment. In this study, we review the g…

AngiogenesisLeftAngiogenesis Inhibitors030204 cardiovascular system & hematologyVentricular Dysfunction Left0302 clinical medicinetyrosine kinase inhibitorNeoplasmstyrosine kinase inhibitorsVentricular DysfunctionMolecular Targeted TherapyEpidermal growth factor receptorSocieties Medicalangiogenesis inhibitors; HER2/epidermal growth factor receptor 2; tyrosine kinase inhibitorABLbiologyDisease ManagementGeneral MedicineItalyCardiovascular DiseasesSupplement Submission030220 oncology & carcinogenesisangiogenesis inhibitors; HER2/epidermal growth factor receptor 2; tyrosine kinase inhibitors; Angiogenesis Inhibitors; Antineoplastic Agents; Cardiology; Cardiomyopathies; Cardiotoxicity; Heart Failure; Humans; Italy; Neoplasms; Practice Guidelines as Topic; Societies Medical; Ventricular Dysfunction Left; Disease ManagementPractice Guidelines as TopicCardiologyCardiology and Cardiovascular MedicineCardiomyopathiesmedicine.medical_specialtyCardiologyAntineoplastic AgentsRisk AssessmentQT interval03 medical and health sciencesGrowth factor receptorInternal medicineMedicalmedicineHumansMonitoring PhysiologicHeart FailureCardiotoxicitybusiness.industryCancerHER2/epidermal growth factor receptor 2medicine.diseaseangiogenesis inhibitors; HER2/epidermal growth factor receptor 2; tyrosine kinase inhibitors; Cardiology and Cardiovascular MedicineCardiotoxicityangiogenesis inhibitorHeart failurebiology.proteinbusinessSocietiesJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct